We represented Salix Pharmaceuticals in cases in multiple jurisdictions alleging renal failure suffered as a result of using a pharmaceutical product. The plaintiffs allegedly suffered renal failure after using a cleansing product that is routinely prescribed prior to a colonoscopy procedure. We conducted the initial investigation into the company’s new drug application, amended warnings, adverse event reports, and other pertinent documents. We collected and preserved the pertinent documents through the use of a complimentary and secure extranet for the client. We identified and interviewed the key company executives and employees involved in the issues that were pertinent to the litigation. These cases focused on the adequacy of the warning labels that accompanied the product and alternative products that were less effective but arguably carried less risk to the patient. One case was dismissed after we deposed the plaintiff and obtained an admission during that deposition that she had just perjured herself after being confronted with a document that contradicted her testimony. Other cases were successfully resolved.
Salix Pharmaceuticals, Inc. (NASDAQ: SLXP) is a specialist pharmaceutical company that develops drugs and medical devices to prevent and treat various gastrointestinal disorders.